Codes / ICD10CM / T38.1X5D

T38.1X5D Adverse effect of thyroid hormones and substitutes, subsequent encounter

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Adverse effect of thyroid hormones and substitutes, subsequent encounter

Summary

This condition represents an adverse effect resulting from thyroid hormones or their synthetic substitutes, documented during a subsequent encounter. It applies to clinical scenarios where a patient experiences harmful effects from these agents after an initial encounter, and the condition is being managed or followed up on. Thyroid hormones regulate metabolism, and adverse effects can arise from therapeutic use, overdose, or individual sensitivity.

Causes

Adverse effects may occur due to therapeutic dosing, accidental or intentional overdose, or idiosyncratic reactions to thyroid hormones or substitutes. The subsequent encounter indicates ongoing management of the adverse effect, which could stem from incorrect dosing, drug interactions, or underlying patient factors affecting metabolism.

Risk Factors

  • Use of thyroid hormone therapies (e.g., levothyroxine) for hypothyroidism or other conditions
  • Polypharmacy involving thyroid agents or interacting medications
  • Renal or hepatic impairment altering drug clearance
  • Individual sensitivity to thyroid substances
  • History of prior adverse reactions to thyroid medications

Symptoms

Symptoms vary based on the nature of the adverse effect and may include tachycardia, tremors, heat intolerance, anxiety, weight loss, or gastrointestinal disturbances. Severe cases can involve cardiac arrhythmias, hyperthermia, or neurological changes. The presentation depends on the extent of exposure and patient-specific factors.

Diagnosis

Diagnosis requires a detailed medication history, clinical assessment of symptoms, and laboratory tests (e.g., thyroid function tests) to confirm abnormal hormone levels. The subsequent encounter context implies prior documentation of the adverse effect, with ongoing evaluation to guide management.

Treatment Options

Management focuses on addressing symptoms, discontinuing or adjusting the offending agent, and providing supportive care. For hyperthyroid symptoms, beta-blockers or antithyroid medications may be used. In cases of overdose, decontamination or enhanced elimination may be considered, depending on the timing and severity.

Prognosis and Follow-Up

Prognosis depends on the severity of the adverse effect and timely intervention. Most cases resolve with appropriate treatment, but severe reactions may require prolonged monitoring. Follow-up ensures resolution of symptoms and adjustment of therapy to prevent recurrence.

Complications

Potential complications include persistent hyperthyroidism, cardiac arrhythmias, or organ damage from severe overdose. Long-term effects may involve thyroid dysfunction or metabolic imbalances if not adequately managed.

Lifestyle & Prevention

Patients should adhere to prescribed dosing, avoid self-adjusting medications, and report adverse effects promptly. Proper storage of thyroid agents and education on signs of toxicity can reduce risks. Regular monitoring of thyroid function is recommended for those on long-term therapy.

When to Seek Professional Help

Seek immediate care for severe symptoms like chest pain, palpitations, fever, or confusion. Contact a healthcare provider for persistent or worsening adverse effects, even if mild, to prevent escalation.

Tips for Medical Coders

Document the adverse effect and its relationship to thyroid hormone use clearly. Note the "subsequent encounter" context, indicating follow-up care. Ensure clinical details support the diagnosis and differentiate from initial encounters or other code categories.

Book a walkthrough

T38.1X5D policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.